Business
Goldman Small Cap Research Issues New Research Report on CBD Life Sciences Inc.
Goldman Small Cap Research Issues New Research Report on CBD Life Sciences Inc..
About this update from Cbd Life Sciences Inc.
[{"type":"text","content":"BALTIMORE, MD / ACCESSWIRE / May 14, 2020 / Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has released a new research report on CBD Life Sciences Inc. (OTC PINK:CBDL). The Company is a diversified CBD Products company. This report carries a price target. To view the new research report, along with disclosures and disclaimers, or to download it in its entirety, please visit https://bit.ly/2Wt8kNk.In the Opportunity Research report, analyst Rob Goldman discusses the potential major sales growth for the Company, driven by key product categories demand along with the current COVID-19 health pandemic.Goldman noted, "With an online presence and a brick and mortar retail location, CBDL is not your typical CBD player. Plus, with dozens of traditional and in-demand specialty products across multiple categories, CBDL is poised to generate meaningful sales growth via its premium products that promote wellness and can improve outcomes in certain maladies. Products include topicals, drops, pain cream, edibles, anxiety & sleep relief , tablets , pre-rolls and pet wellness offerings which are available on a wholesale and retail basis.""The Company's Hand Sanitizers are huge sellers given the COVID-19 outbreak and other skin care offerings are popular as well," Goldman stated. Sales of anti-anxiety supplements are also on the rise among Gen Z and Millennials due to the COVID-19 situation. Separately, exposure to the burgeoning Pet CBD wellness space with their diverse offerings could generate major sales in an industry segment slated to grow from $31M in sales in 2018 to $1.7B in 2025.""Looking ahead, even with a conservative 2021 sales estimate of and a low-end price to sales multiple should result in a substantial rise in company valuation," concluded Goldman.About Goldman Small Cap Research: Founded in 2009 by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and microcap stock research reports, articles, stock market blogs, and popular investment newsletters.Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.This press release contains excerpts of our most recently published sponsored company...